The DSRU team is attending the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia.
Come and meet our team at booth 204, where you can find out about our hospital PASS studies, our CPRD studies and DSRU Consulting.
Find out about our research from our posters:
Monday 26th August Characterisation of Drug Interaction Related Signals Leading to EU Regulatory Action and a Methodological Review of Novel Drug Interaction Signal Detection Methods in the Post-Marketing Setting D Roy, L Hazell, V Osborne, S Shakir
Impact Analyses of European Pharmacovigilance Interventions on Public Health Burden S Lane, E Lynn, J Slattery, S Shakir
Wednesday 28th August Monitoring the Safety of Exenatide Once-Weekly (Bydureon®) in Primary Care in England: Results from a PASS S Dhanda, V Osborne, D Roy, S Shakir
Utilisation of Exenatide Once-Weekly (Bydureon®) in Primary Care in England: Results from a PASS S Dhanda, V Osborne, D Roy, S Shakir
Utilisation Of Dulaglutide In Primary Care In England: Interim Results from a Post Authorisation Safety Study M Davies, L Hazell, S Dhanda, V Osborne, A K Ali, S Shakir
The Association between Direct Oral Anticoagulants and Gynaecological Bleeding in Women v. Standard Therapy: A Systematic Review S Dhanda, V Osborne, S Shakir
Risk Factors of Major Bleeding in Patients Prescribed Rivaroxaban in Primary Care in England D Roy, S Dhanda, L Wise, S Shakir